These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33342308)

  • 1. The management of hematologic malignancies during the COVID-19 pandemic.
    Hus I; Salomon-Perzyński A; Tomasiewicz K; Robak T
    Expert Opin Pharmacother; 2021 Apr; 22(5):565-582. PubMed ID: 33342308
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment Approaches for Managing Patients with Hematological Malignancies in the Time of COVID-19 Pandemic.
    Seval GC; Topçuoğlu P; Demirer T
    Turk J Med Sci; 2021 Dec; 51(6):2799-2809. PubMed ID: 33705648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.
    Buske C; Dreyling M; Alvarez-Larrán A; Apperley J; Arcaini L; Besson C; Bullinger L; Corradini P; Giovanni Della Porta M; Dimopoulos M; D'Sa S; Eich HT; Foà R; Ghia P; da Silva MG; Gribben J; Hajek R; Harrison C; Heuser M; Kiesewetter B; Kiladjian JJ; Kröger N; Moreau P; Passweg JR; Peyvandi F; Rea D; Ribera JM; Robak T; San-Miguel JF; Santini V; Sanz G; Sonneveld P; von Lilienfeld-Toal M; Wendtner C; Pentheroudakis G; Passamonti F
    ESMO Open; 2022 Apr; 7(2):100403. PubMed ID: 35272130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing patients with hematological malignancies during COVID-19 pandemic.
    Sahu KK; Cerny J
    Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
    [No Abstract]   [Full Text] [Related]  

  • 5. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
    Naimi A; Yashmi I; Jebeleh R; Imani Mofrad M; Azimian Abhar S; Jannesar Y; Heidary M; Pakzad R
    J Clin Lab Anal; 2022 May; 36(5):e24387. PubMed ID: 35385130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical management of the patients with hematological diseases during the COVID-19 pandemic in Japan].
    Hagihara M; Ohara S; Uchida T; Inoue M
    Rinsho Ketsueki; 2021; 62(2):115-124. PubMed ID: 33678770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals.
    Noun P; Ibrahim A; Hodroj MH; Bou-Fakhredin R; Taher AT
    Expert Rev Hematol; 2020 Oct; 13(10):1081-1092. PubMed ID: 32931348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
    Modemann F; Niederwieser C; Weisel K; Bokemeyer C; Fiedler W; Ghandili S
    Leuk Lymphoma; 2022 Mar; 63(3):664-671. PubMed ID: 34668809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
    SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
    Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey.
    Levy I; Sharf G; Norman S; Tadmor T
    Support Care Cancer; 2021 Dec; 29(12):7591-7599. PubMed ID: 34128108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study.
    Goudsmit A; Cubilier E; Meert AP; Aftimos P; Stathopoulos K; Spilleboudt C; Loizidou A
    Support Care Cancer; 2021 Nov; 29(11):6271-6278. PubMed ID: 33851236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic.
    Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N
    Intern Med J; 2020 Jun; 50(6):667-679. PubMed ID: 32415723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in hematological malignancies: Case series and literature review.
    Ocheni S; Nwagha TU; Amu N; Obodo OI; Okereke K; Chikezie K; Ejezie CS; Ilechukwu GU; Obiatuegwu C
    Ann Afr Med; 2023; 22(3):381-384. PubMed ID: 37417029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
    Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
    Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation during COVID-19 pandemic: experience from a tertiary hospital in Madrid.
    Lázaro Del Campo P; Ramírez López A; de la Cruz Benito B; de Paz Arias R; de Soto Álvarez T; Sánchez Vadillo I; Humala Barbier K; García Pérez E; Dos Santos Ortas A; López de la Guía A; Gasior Kabat M; Baltasar Tello P; Jiménez Yuste V; Canales Albendea M
    Expert Rev Hematol; 2021 Jan; 14(1):1-5. PubMed ID: 33280467
    [No Abstract]   [Full Text] [Related]  

  • 16. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
    Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
    PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the COVID-19 Pandemic Reshaped the Management of Leukemia and Affected Patient Outcomes.
    Sharafeldin N; Bates B; Vachhani P
    Curr Treat Options Oncol; 2022 May; 23(5):688-702. PubMed ID: 35334062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.
    Crosby DL; Sharma A
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):16-24. PubMed ID: 32340549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in patients with hematological malignancies: A retrospective case series.
    Infante MS; González-Gascón Y Marín I; Muñoz-Novas C; Churruca J; Foncillas MÁ; Landete E; Marín K; Ryan P; Hernández-Rivas JÁ
    Int J Lab Hematol; 2020 Dec; 42(6):e256-e259. PubMed ID: 32749757
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections.
    Moreno-Sanchez F; Gomez-Gomez B
    Curr Oncol Rep; 2022 Jul; 24(7):835-842. PubMed ID: 35316843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.